Skip to main content

Archive: Wed Dec 2016

The Tricky Business of Targeting Cancers' "Master Regulators"

Drug delivery using nanotechnology for cancer therapy [Image: NIH Image Gallery]Over the past few decades, cancer therapies have become increasingly targeted, with protein and antibody drugs targeting specific proteins with exquisite selectivity. Often,…